Patch pump under development with commercialization expected by the end of 2027 One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of ...

Two manufacturers of automated insulin delivery (AID) systems, Tandem Diabetes Care and Beta Bionics, have updated their products to integrate with the Dexcom G7 continuous glucose monitoring (CGM) ...

Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...

For development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump and pump systems “We’re excited to be partnering with Beta Bionics by ...

As per the analyst, the insulin pumps are a double-digit growth category, with the company taking share from the low base. The firm believes that Beta Bionics, Inc. (NASDAQ:BBNX)’s revenue in the US ...